Myfortic 360 mg

MYFORTIC 360 MG is an enteric-coated tablet containing mycophenolic acid (mycophenolate sodium), used for immunosuppression. This medication is commonly prescribed to prevent organ rejection post-transplant.

MYFORTIC 360 MG is primarily used to prevent rejection in organ transplant patients. It works by suppressing the immune system to help the body accept the transplanted organ. This medication is often prescribed for kidney, heart, or liver transplants. What is MYFORTIC used for? It is used to manage immune responses in transplant recipients, ensuring the body does not reject the new organ.

Common effects of MYFORTIC 360 MG may include gastrointestinal issues such as diarrhea, nausea, or vomiting. Some users might experience fatigue or infections due to the immunosuppressant nature of the drug. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

MYFORTIC 360 MG should be handled with care, as it can increase the risk of infections and certain cancers due to its immunosuppressant properties. Regular blood tests may be required to monitor blood cell counts and liver function. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider.

MYFORTIC 360 MG may interact with other medications, including antacids, cholestyramine, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided as it can exacerbate side effects.